Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Terrier

Showing results (161-170 of 444) with videos related to

Pageof 45
Sort By:
Arthritis and Rheumatism|December 8, 2011
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritisBenjamin Terrier, Guillaume Geri, Wahiba Chaara, et al.
Orphanet Journal of Rare Diseases|April 7, 2021
Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, et al.
The Journal of Allergy and Clinical Immunology|July 5, 2011
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet diseaseGuillaume Geri, Benjamin Terrier, Michelle Rosenzwajg, et al.
Clinical and Experimental Rheumatology|June 5, 2019
Abdominal adipose tissue predicts major cardiovascular events in systemic necrotising vasculitidesKarine Briot, Bertrand Dunogué, Soledad Henriquez, et al.
Orphanet Journal of Rare Diseases|December 29, 2020
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, et al.
International Journal of Rheumatology|July 24, 2013
Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related DiseaseAurélie Grados, Mikael Ebbo, José Boucraut, et al.
ERJ Open Research|January 10, 2024
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristicsDavid R W Jayne, Benjamin Terrier, Bernhard Hellmich, et al.
ACR Open Rheumatology|June 13, 2023
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic PhenotypeBenjamin Terrier, David R W Jayne, Bernhard Hellmich, et al.
Oncoimmunology|September 18, 2018
Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatmentFréderic Franconieri, Samuel Deshayes, Hubert de Boysson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2023
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance TherapyNihel Khoudour, Florence Delestre, Fabienne Jabot-Hanin, et al.
Pageof 45

Showing results (161-170 of 444) with videos related to

Sort By:
Pageof 45
Arthritis and Rheumatism|December 8, 2011
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritisBenjamin Terrier, Guillaume Geri, Wahiba Chaara, et al.
Orphanet Journal of Rare Diseases|April 7, 2021
Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, et al.
The Journal of Allergy and Clinical Immunology|July 5, 2011
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet diseaseGuillaume Geri, Benjamin Terrier, Michelle Rosenzwajg, et al.
Clinical and Experimental Rheumatology|June 5, 2019
Abdominal adipose tissue predicts major cardiovascular events in systemic necrotising vasculitidesKarine Briot, Bertrand Dunogué, Soledad Henriquez, et al.
Orphanet Journal of Rare Diseases|December 29, 2020
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)Benjamin Terrier, Raphaël Darbon, Cécile-Audrey Durel, et al.
International Journal of Rheumatology|July 24, 2013
Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related DiseaseAurélie Grados, Mikael Ebbo, José Boucraut, et al.
ERJ Open Research|January 10, 2024
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristicsDavid R W Jayne, Benjamin Terrier, Bernhard Hellmich, et al.
ACR Open Rheumatology|June 13, 2023
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic PhenotypeBenjamin Terrier, David R W Jayne, Bernhard Hellmich, et al.
Oncoimmunology|September 18, 2018
Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatmentFréderic Franconieri, Samuel Deshayes, Hubert de Boysson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2023
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance TherapyNihel Khoudour, Florence Delestre, Fabienne Jabot-Hanin, et al.
Pageof 45